Mirataz is a drug owned by DECHRA, LTD. It is protected by 1 US drug patent filed in 2036. All patents are active. Details of Mirataz’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US010603672 | Active | |
Exclusivity Information
Mirataz holds 1 exclusivity out of which 1 has expired. Details of Mirataz's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCE | May 04, 2023 |
About Mirataz
Mirataz is a drug
owned by DECHRA, LTD.
Mirataz uses
Mirtazapine as the active
ingredient.
Active Ingredient:
Mirataz uses
Mirtazapine as the active ingredient.
Check out other Drugs and Companies using
Mirtazapine ingredient.